London, United Kingdom

Nicola Robas

 

 

Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...
Loading Chart...

Title: Nicola Robas - Innovator in Pharmaceutical Compounds

Introduction: Nicola Robas is an inventor based in London, GB, known for his contributions to the field of pharmaceutical compounds. He currently works at BenevolentAI Cambridge Limited, where he focuses on developing innovative solutions for medical challenges. Although he has not yet been granted any patents, his work is significant in the realm of research and development.

Latest Patent Applications: Nicola Robas has submitted several notable patent applications, including:

1. **Imidazole Organic Compounds and Their Use Against Inflammatory Bowel Disease** - This invention relates to compounds of Formula (I) or a pharmaceutically acceptable salt, solvate, hydrate, tautomer, optical isomer, and/or N-oxide thereof. The invention also encompasses the processes for the preparation of these compounds, pharmaceutical compositions comprising these compounds, and their uses in treating diseases or conditions associated with inflammatory bowel disease (IBD), particularly ulcerative colitis (UC) and Crohn's disease (CD).

2. **Organic Pyridine-Pyrazole Compounds and Their Uses** - This application pertains to compounds of Formulae (IA), (IB), (IIA), and (IIB) or a pharmaceutically acceptable salt, solvate, hydrate, tautomer, optical isomer, N-oxide, and/or prodrug thereof. Similar to the previous application, it relates to the processes for the preparation of these compounds, pharmaceutical compositions comprising these compounds, and their uses in treating diseases or conditions associated with inflammatory bowel disease, specifically ulcerative colitis and Crohn's disease.

Conclusion: Nicola Robas is an emerging inventor whose work in pharmaceutical compounds holds promise for addressing significant medical issues. His latest patent applications reflect his commitment to innovation in the field of healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…